NCT02927964 2024-10-16TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular LymphomaStanford UniversityPhase 1/2 Completed21 enrolled 11 charts
NCT01769222 2024-01-24Ipilimumab and Local Radiation for Selected Solid TumorsStanford UniversityPhase 1 Terminated3 enrolled 5 charts
NCT00088881 2017-05-25Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Terminated62 enrolled 8 charts